East Bay drug maker soars 700 percent on Wall Street with plan to NOT make drugs

It's burned through $1.2 billion and never brought a drug to market in its 37 years. So why did Wall Street send this company's stock price soaring last year?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.